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Abstract A group of ATP-binding cassette (ABC) transporters, 
including the yeast cadmium transporter (YCF1), the mamma-
lian multidrug resistance-associated protein (MRP), the multi-
specific organic anion transporter and its congener (MOAT and 
EBCR), as well as the sulfonylurea receptor (SUR), group into a 
subfamily by sequence comparison. We suggest that these MRP-
related proteins are also characterized by a special, common 
membrane topology pattern. The most studied ABC transporters, 
the cystic fibrosis transmembrane conductance regulator (CFTR) 
and the multidrug resistance (MDR) proteins, were shown to 
contain a tandem repeat of six transmembrane helices, each set 
followed by an ATP-binding domain. According to the present 
study, in contrast to various membrane topology predictions 
proposed for the different MRP-related proteins, they all seem to 
have a CFTR/MDR-like core structure, and an additional, large, 
N-terminal hydrophobic region. This latter domain is predicted 
to contain 4-6 (most probably 5) transmembrane helices, and is 
occasionally glycosylated on the cell surface. Since all the MRP-
related transporters were shown to interact with anionic 
compounds, the N-terminal membrane-bound domain may have 
a key role in these interactions. 
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1. Introduction - the ABC transporters 
The so-called ATP-binding cassette (ABC) transporters, 
present from bacteria to man, are involved in the ATP-de-
pendent transport of a great variety of compounds, ranging 
from inorganic ions to large polypeptides. In most cases these 
proteins were demonstrated to function as transport ATPases, 
that is hydrolyzing ATP in conjunction with transporting their 
substrate molecules through cellular or intracellular mem-
branes [1-3]. The ABC transporters, forming one of the larg-
est known protein family, are built from combinations of 
conservative domains, that is ATP- (nucleotide-) binding 
ABC units, and characteristic membrane-bound regions. 
The ABC units harbor the highly conserved 'Walker A' and 
'Walker B' sequences, most probably directly responsible for 
the interaction with ATP or other nucleotides [4]. These 
Walker sequences are separated by a stretch of about 120-
170 amino acids, including a short (12-13 amino acid) peptide 
motif, called the ABC transporter 'signature' region, which is 
in fact diagnostic for these proteins [5,6]. The membrane-
bound domains of the ABC transporters in most cases were 
'Corresponding author. Fax: (36) (1) 185-2234. 
predicted to contain six transmembrane (TM) helices, and in 
some bacterial and in all eukaryotic ABC transporters at least 
one ABC unit and one transmembrane domain are encoded 
by a single gene [1-3,6]. 
Characteristic eukaryotic ABC transporters are the yeast 
pheromone transporter, STE6, the mammalian multidrug re-
sistance (MDR) proteins, producing a drug resistance pheno-
type in cancer cells, and the human cystic fibrosis transmem-
brane conductance regulator (CFTR), the mutations of which 
are causative in the lethal disease of cystic fibrosis. These 
proteins were all suggested to consist of a tandem repeat of 
six TM helices, each set of helices followed by an ABC unit. 
Such a basic structure and membrane topology with 6+6 TM 
helices in CFTR and MDR has already been experimentally 
confirmed [7-9]. There are several examples of the expression 
of 'half-MDR'-like proteins, which contain only one trans-
membrane region (with probably six TM helices) and one 
ABC unit. Still, e.g. the mammalian peptide transporter pro-
teins of this type, involved in the MHCI-dependent antigen 
presentation process (TAP1 and TAP2), have already been 
shown to form functional heterodimers in the membrane en-
vironment [10]. 
2. The MRP family 
In 1992, Cole at al. [11] reported the molecular cloning and 
characterization of the human multidrug resistance-associated 
protein (MRP), a large (190 kDa) membrane glycoprotein, 
which belongs to the group of ABC transporters and causes 
a multidrug resistance phenotype in cancer cells. MRP prob-
ably transports both hydrophobic anticancer agents and 
anionic (e.g. glutathione) drug conjugates, and its physiolog-
ical functioning may provide a wide range of xenobiotic resist-
ance [12-15]. During the past few years numerous homologs of 
MRP have been identified. These include the yeast cadmium 
factor (YCF1), which transports metallothionein-conjugated 
metal ions [16] and glutathione conjugates [17], and the mam-
malian sulfonylurea receptors (SURI and SUR2), which are 
glycoproteins present in pancreatic ß cells and in cardiac and 
skeletal muscle, respectively, and are involved in the regulation 
of ATP-sensitive K+ channels [18,19]. In 1996, the discovery of 
the MRP-related liver canalicular multispecific organic anion 
transporter (cMOAT) [20,21], exporting conjugated bile salts, 
and its close homolog, the rabbit epithelial basolateral chloride 
conductance regulator (EBCR), indicated to regulate specific 
chloride channels [22], was reported. 
According to the original sequence analysis [11], MRP was 
predicted to contain 8+4 TM helices, each set of helices fol-
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Fig. 1. Relative similarity dendrogram (A) and aligned hydrophobicity plots (B) of selected ABC transporter proteins. A: The relative similarity 
dendrogram was constructed using the PILEUP program. For the sake of better visualization MDR and CFTR sequences are represented as 
single branches on the tree. B: Hydrophobicity plots were generated according to von Heijne [25]. The plots are aligned in a way that the 
highly conserved Walker A consensus sequence motifs in the N-terminal (WaAi) and in the C-terminal (\VaA2) ABC units are in register. The 
shaded areas (TM0, TMi and TM2) indicate hydrophobic, membrane-bound regions; black areas show transmembrane helices with locations 
experimentally confirmed in human CFTR and human MDR1. The membrane-bound domains, the two conserved ATP-binding cassette (ABCi 
and ABC2) regions, and the regulatory (R) domain of CFTR, are indicated. Gaps are shown as horizontal dashed lines. The GenBank 
(EMBL) accession numbers for the proteins used in this comparison are the following: M14758 (MDR1_HUMAN); M28668 (CFTR_HU-
MAN); Z49144 (EBCR_RABBIT); L49379 (cMOAT_RAT); X96395 (cMOAT_HUMAN); 1488428 (MRP_MOUSE); L05628 (MRP_HU-
MAN); U66261 (MRP_CAEEL); L35237 (YCF1_YEAST); L78207 (SUR_HUMAN); L40624 (SUR_RAT); D83598 (SUR2_RAT). Note: In 
the same kind of search using the BLAST program [27] in the non-redundant combination of databases provided by NIH, we have also found 
several other expressed or probable protein sequences with as yet unknown functions, resulting from genome sequencing projects, which may 
belong to this MRP-like subfamily. These include both nematode (Genbank accession number: Z68113, Z81016 and U41554) and yeast 
(X97560, Z73153, Z69369, U41554, and Z 28328+Z 28329) sequences 
lowed by an ABC unit, and possible glycosylation sites could 
be found on the extracellular loops between helices 3-4, 9-10, 
and 11-12. Interestingly, in the original sequence analyses, 
YCF1 was predicted to contain 6+6, SUR 9+4, and cMOAT 
and EBCR 8+4 TM helices, again each set of helices followed 
by an ABC unit. 
3. Membrane topology of MRP 
Recently, based on antibody binding and limited proteolysis 
experiments [23], we have demonstrated that the human MRP 
contains three major membrane-bound domains, separated by 
two cytoplasmic loops. The first and last membrane-bound 
domains were found to be glycosylated when MRP was ex-
pressed in mammalian cells. These data and the hydrophobic-
ity analyses of the aligned sequences of MRP and its close 
relative, the human CFTR, suggested a different membrane 
topology model than originally predicted by Cole et al. [11]. 
We proposed that MRP contains an N-terminal hydrophobic, 
membrane-bound, glycosylated domain (with 4-5 TM heli-
ces), which is fused with a CFTR-like region, containing the 
tandem repeat of the conservative six TM helices, each set of 
helices followed by an ABC unit. A recent communication by 
Cole et al. [24] suggests a similar membrane topology pattern 
both for the human and the mouse MRP. These results raised 
the question if a similar membrane topology pattern may be 
present in the other MRP-related proteins as well. 
4. Similarity dendrogram and hydrophobicity plots of 
MRP-related proteins 
In order to identify all probable MRP-related proteins, we 
have estimated the evolutionary relationships by sequence 
comparisons within the ABC transporter family. A relative 
similarity dendrogram (Fig. 1A) has been constructed using 
the PILEUP program and a non-redundant combination of 
databases provided by NIH, considering the amino acid se-
quences of all ABC transporters which have at least one 
ABC unit and one transmembrane domain encoded within 
the same gene. This analysis indicated that the MDR and 
CFTR sequences from numerous species group into separate 
subfamilies, while clustering around the MRP we have found a 
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recognizable subfamily, containing all the expected MRP-re-
lated proteins. As indicated in the legend to Fig. 1, several 
other uncharacterized protein sequences also grouped into 
this subfamily. 
In the following we have generated hydrophobicity plots 
from the sequences of all the analyzed ABC transporter pro-
teins, according to the method of von Heijne [25]. These plots 
were then aligned in a way that the highly conserved Walker 
A consensus sequence motifs in the N-terminal (WaAi) and in 
the C-terminal (\VaA2) ABC units were in register. In Fig. IB 
we present the aligned hydrophobicity plots of some of the 
key proteins (printed bold) from each group. 
As emphasized by the shaded area in Fig. 1, the basic 6 TM 
helices-ABC unit-6 TM helices-ABC unit structure can be 
recognized in each protein presented. However, in addition 
to this basic pattern, the hydrophobicity plots in the MRP-
related subfamily indicate that all these proteins contain an N-
terminally located, large, hydrophobic, most probably mem-
brane-bound domain, with 4—6 helices (labeled here TM0), not 
present in MDRs or CFTRs. These data suggest that the pre-
vious membrane topology predictions for MRP, cMOATs and 
EBCR (8+4 helices), YCF1 (6+6 helices), or SURs (9+4 TM 
helices), yielded variable numbers because of including and/or 
missing some TM helices both from the CFTR/MDR-like core 
structure and the N-terminal hydrophobic domain. 
From the data currently available, the actual number of TM 
helices in the N-terminal membrane-bound domain of the 
MRP-related proteins is hard to predict. Although the se-
quence analysis of the TMo domains shows a relatively low 
level of similarity (11-25%), due to the exchangeability of the 
hydrophobic amino acids in the TM regions, the membrane 
insertion and folding patterns are most probably better con-
served than the actual amino acid sequences. In the case of 
SURI, a possible JV-glycosylation site in position 10 was 
shown to be indeed glycosylated, placing the N-terminal region 
of this protein to the external surface of the cell membrane [18]. 
Also, all the mammalian proteins in this group contain one or 
two possible 7V-glycosylation sites within the first 25 residues. 
These observations suggest that the N-terminal regions of the 
mammalian MRP-related proteins are extracellularly located, 
and the TMo region may contain 5 TM helices. 
5. Conclusions 
The data presented here indicate that by a proper alignment 
of the protein sequences of the ABC transporters, a character-
istic modular membrane topology arrangement becomes ap-
parent for the MRP-related subfamily. These proteins seem to 
contain a CFTR/MDR-like domain arrangement, and an ad-
ditional, N-terminal hydrophobic region, with a probably 
conserved membrane insertion pattern, but with a low level 
of sequence similarity. When this membrane topology pattern 
was visually compared to that of other ABC transporters, we 
observed that some 'half-MDR'-like proteins contain a simi-
lar, relatively large N-terminal hydrophobic region. This was 
especially apparent in the case of the yeast metal resistance 
ABC transporter protein, HMTl, transporting anionic metal 
complexes [26]. Since all the MRP-related proteins interact 
with and/or transport large organic anions, a common func-
tional role of the N-terminal membrane-spanning region may 
involve such an interaction. 
We suggest that in the case of membrane proteins, in addi-
tion to sequence comparisons, topology pattern analysis may 
significantly help the search for characteristic domains. Mech-
anistic application of the widely available computerized mem-
brane topology prediction programs may be misleading, while 
alignments according to strongly conserved domains and con-
sidering experimentally confirmed structures may significantly 
improve such predictions. 
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